Reversible cerebral vasoconstriction syndrome in a methylphenidate-treated patient: a case report
The role of methylphenidate needs to be considered in case of RCVS diagnosis observed in a treated patient. Although the frequency of this potential adverse drug reaction is expected to be rare, clinicians should be aware of its possible occurrence, given the ever-increasing use of methylphenidate.
Authors
- Lucie‐Marie Scailteux (ORCID: https://orcid.org/0000-0001-7047-9107)
- Emmanuelle Herlem
- Marie‐Noëlle Osmont (ORCID: https://orcid.org/0000-0001-7472-8780)
- Élisabeth Polard
- Cécile Malrain
- Anne-Lise Ruellan
- Amine Benchikh
Institutions
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Centre Hospitalier Universitaire de Reims (FR)
- Pitié-Salpêtrière Hospital (FR)
- Centre Hospitalier Universitaire de Rennes (FR)
- Université de Rennes (FR)
- Université de Reims Champagne-Ardenne (FR)
Publication Details
- Journal
- BMC Neurology
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1186/s12883-024-04004-4
- Citations
- 4
- Primary Topic
- Neurological Complications and Syndromes
- Type
- article
- Field-Weighted Citation Impact
- 1.54